Dr. Patel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1583 Health Care Dr
Rock Hill, SC 29732Phone+1 803-329-7772Fax+1 803-329-9821
Summary
- Kashyap Patel is the CEO of Carolina Blood and Cancer Care Associates. Dr. Patel is a practicing medical oncologist, board certified in Hematology, Oncology, and Internal Medicine. He is immediate past president for the Community Oncology Alliance (COA), He is past for the clinical affairs and trustee for the Association of Community Cancer Centers (ACCC). He has published/presented over 130 papers. He is frequently interviewed and cited in mainstream newspapers including NY times, Washington Post, NPR just to name a few including on key issues like Covid 19, Healthcare disparities, value-based care. He is also frequenly invited by WH team to opine of Cancer Moonshot program
He has been an advisor for the large payers including DHHS (SC), Palmetto GBA, and serves on an advisory board for Medicaid HMOs. He has a special interest in health care policy and economics, and he has expertise in Value Based Care and has successfully led Oncology Care Model pilots with two payers including with CMMI
Additionally, Dr Patel has been working directly with cancer patients for the last twenty years. He has served as chairman of several committees in numerous South Carolina hospitals. Moreover, he has extensive research experience in oncology. Dr. Patel has extensive legislative experience both at the local and national level. He has testified in state senate as well as has carried out capitol hill briefing on precision medicine.
He has been honored by the US Congress for his exceptional contribution to the healthcare. Multiple journals have written about his life. He is now working with multiple national entities on cancer health disparities
Education & Training
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Hematology and Medical Oncology, 1999 - 2002
- Jamaica Hospital Medical CenterResidency, Internal Medicine, 1996 - 1999
- N.H.L Municipal Medical CollegeClass of 1984
Certifications & Licensure
- NC State Medical License 2003 - 2025
- SC State Medical License 2002 - 2025
- NY State Medical License 1999 - 2018
- FL State Medical License 2002 - 2006
- PA State Medical License 1999 - 2006
- NJ State Medical License 2000 - 2005
- MI State Medical License 1999 - 2000
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Publications & Presentations
PubMed
- HSR24-142: Real-World Clinical Benefit Among Patients (pts) With Lower-Risk Myelodysplastic Syndromes (LR-MDS) Treated With Luspatercept.Kashyap Patel, Brandy Snyder, Derek Tang, Debanjana Chatterjee, Anupama Vasudevan
Journal of the National Comprehensive Cancer Network. 2024-04-05 - HSR24-133: Real-World (RW) Effectiveness of Erythropoiesis-Stimulating Agents (ESAs) After Luspatercept in Patients (pts) With Myelodysplastic Syndromes (MDS): A Retro...Kirollos S Hanna, Rui Song, Samantha Slaff, Enrico Zanardo, Lynn Huynh
Journal of the National Comprehensive Cancer Network. 2024-04-05 - 64 citationsThe cost savings of biosimilars can help increase patient access and lift the financial burden of health care systems.Tore K Kvien, Kashyap Patel, Vibeke Strand
Seminars in Arthritis and Rheumatism. 2022-02-01
Press Mentions
- Oxford Biodynamics to Present on Its Line of EpiSwitch® Products for Companion Diagnostics in Cancer Immunotherapy at the 14th World Summit for Clinical Biomarkers and Companion Diagnostics in Boston, MAJuly 25th, 2024
- Covid Might Be to Blame for an Uptick in Rare CancersJune 20th, 2024
- Rare and ‘Unusual’ Cancers Are Emerging After the Covid Pandemic – and Doctors Fear an Unlikely Culprit Is to BlameJune 7th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: